Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Semaglutide by Chia Tai Tianqing Pharmaceutical Group for Type 2 Diabetes: Likelihood of Approval
Semaglutide is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase III for Type 2 Diabetes....